Navigation Links
Study in PLoS: Intensive adherence counseling to HIV treatment improves patient outcomes
Date:3/2/2011

Intensive adherence counseling around the time of HIV treatment initiation significantly reduces poor adherence and virologic treatment failure in sub-Saharan Africa, according to a recent study in PLoS Medicine by Dr. Michael Chung, assistant professor of Global Health at University of Washington, who works at the Coptic Hope Center for Infectious Diseases in Nairobi, Kenya.

The study published March 1 also found that using an alarm device has no effect on adherence counseling.

The findings of this study define an adherence counseling protocol that is effective and highly relevant to other HIV clinics caring for large numbers of patients in sub-Saharan Africa. As poor adherence to HIV treatment can lead to drug resistance and inadequate treatment of HIV, it is necessary to identify adherence interventions that are inexpensive and proven to be effective in resource-limited settings. The study complements a recent study on cell-phone strategies to increase adherence to HIV treatment published in Lancet 2010, which Chung also contributed as a co-author.

Chung helped the Coptic Hospital in Kenya establish the Hope Clinic, a free HIV care and treatment clinic. In 2004, this relationship led to a collaboration between the University of Washington and the Coptic Mission to provide free HIV care and treatment to Kenyans with support from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). By 2010, more than 16,000 HIV-infected Kenyans have received medical treatment at the Coptic Hope Centers for Infectious Diseases.

In this recent study, the authors randomized 400 patients who were newly diagnosed with HIV and had never before taken antiretroviral therapy to receive adherence counseling alone; alarm device alone; both adherence counseling and alarm device together; and a control group that received neither adherence counseling nor alarm device.

Patients had baseline blood levels and then every six months for the duration of the study18 months. After starting HIV treatment, patients returned to the study clinic every month with their pill bottles for the study pharmacist to count and recorded the number of pills remaining in the bottle.

Patients receiving adherence counseling were 29 percent less likely to experience poor adherence compared to those who received no counseling. Furthermore, those receiving intensive early adherence counseling were 59 percent less likely to experience viral failure. However, there was no significant difference in mortality or significant differences in CD4 counts at 18 months follow-up between those who received counseling and those who did not. There were also no significant differences in adherence, time to viral failure, mortality, or CD4 counts in patients who received alarm devices compared to those who did not.

The authors conclude: "As antiretroviral treatment clinics expand to meet an increasing demand for HIV care in sub-Saharan Africa, adherence counseling should be implemented to decrease the development of treatment failure and spread of resistant HIV."


'/>"/>

Contact: Michael Chung
mhchung@uw.edu
206-543-4278
University of Washington - Health Sciences/UW News, Community Relations & Marketing
Source:Eurekalert

Related medicine news :

1. Study Finds Smoking Linked to Breast Cancer Risk
2. Heart Devices Not Tested Enough in Women: Study
3. Study Rates Success of Corneal Transplants in Kids
4. Half of U.S. Men Infected With HPV, Study Reveals
5. A small subset of normal white blood cells gives rise to a rare leukemia, study shows
6. Study: Happiness improves health and lengthens life
7. New study: Medical and financial impact of drug-related poisonings treated in US EDs
8. Study links vitamin D to lung cancer survival
9. Global ISU study: Invasive species widespread, but not more than at home range
10. Sugary Drinks Might Raise Hypertension Risk: Study
11. Hospital use of virtual colonoscopy is on the rise, study suggests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... ... financial consultation services to residents in the Sacramento/Folsom region, is initiating a charity ... facility. , The Another Choice Another Chance treatment center in Sacramento works to ...
(Date:12/7/2016)... ... December 07, 2016 , ... A. Kevin Spann Insurance, ... families throughout the Five Boroughs, is launching a charity drive to raise funds that ... the traditions and spirit of marines and Navy FMF Corpsmen. Working closely with the ...
(Date:12/7/2016)... ... December 07, 2016 , ... Facial plastic surgeon, Dr. John D. Rachel ... a portion of proceeds to two local organizations: North Chicago Animal Control and Friends ... is a team of authorized and trained volunteers who support rescued animals held ...
(Date:12/7/2016)... ... December 07, 2016 , ... The medical profession is well aware that heart ... major study analyzing heart attacks among 138,602 people recorded a 35% higher number of ... would all agree of course–no time of year is a good time for a ...
(Date:12/7/2016)... Norwalk, CT (PRWEB) , ... December 07, 2016 ... ... the Integrated Infertility and Wellness (IFW) Program at Reproductive Medicine Associates of Connecticut ... which now has a team of three acupuncturists to help patients realize their ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... 7, 2016  Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ), ... a company overview at the BMO Capital Markets Prescriptions for Success ... NY . A live webcast of the presentation ... Ionis website.  The replay will be available within 48 hours and ... ...
(Date:12/7/2016)... (NYSE: LCI ) today announced that the company will ... Conference on December 14, 2016 at 9:20 a.m. (ET) at the ... In addition, the company will host one-on-one meetings with ... Boston Healthcare Conference taking place on December 13, 2016 at the ... , , ...
(Date:12/6/2016)... -- Alopexx Oncology, LLC announced data from a Phase I ... composed of interleukin-2 and a CD20-targeting monoclonal antibody. The ... as Rituxan and maintains the activities of both the ... tumor targeting, engagement of the immune system, and induction ... study (abstract #95954) were presented at the 58 th ...
Breaking Medicine Technology: